Senores Pharma Announces 9th AGM on Sep 25, 2026, with E-voting Facility
Senores Pharmaceuticals Limited will hold its 9th AGM on September 25, 2026, via video conference. Shareholders can e-vote from September 22-24, 2026, through the Linkintime portal. The AGM notice and related documents are available on the company website and stock exchanges.
The announcement pertains to a standard annual general meeting, a routine corporate event. It does not involve any significant financial transactions, business strategy changes, or operational updates that would have a material impact on the company's stock or business operations.
The announcement is a routine corporate event (AGM) and does not contain any specific financial performance indicators or strategic decisions that would sway sentiment positively or negatively.
Senores Pharmaceuticals Limited has announced its Ninth (9th) Annual General Meeting (AGM) of the Members of the Company.
The AGM is scheduled to be held on Thursday, September 25, 2026, at 02:30 PM Indian Standard Time (IST). The meeting will be conducted through video conferencing (VC) or other audio-visual means (OAVM).
In connection with the AGM, the company has published newspaper advertisements in Financial Express (English) and its Gujarati edition. The intimation is also available on the company's website, www.senorespharma.com. The company is also providing an e-voting facility for shareholders, with the remote e-voting period commencing on September 22, 2026, at 09:00 AM IST and ending on September 24, 2026, at 05:00 PM IST. The AGM proceedings will also be webcast live on the e-voting platform.
Shareholders can access the AGM details and cast their votes through the e-voting portal: https://instavote.linkintime.co.in. Further details regarding the AGM, including the Annual Report and AGM Notice, will be made available on the company's website and stock exchange websites.
What to do with a filing like this
Senores Pharmaceuticals Limited filed this with the NSE as a statutory disclosure, categorised under agm. It is a primary document, not a recommendation, and the desk marks it low impact, the band that almost never moves a portfolio on its own.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Senores Pharmaceuticals Limited. Read the original for the full detail.